Enrique Poradosu
CIK: 0001898147
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCT
Nuvectis Pharma, Inc.
Officer
Discretionary Trading P&L
Holdings
About Poradosu Enrique
Poradosu Enrique (SEC CIK 0001898147) files insider reports with the SEC as Chief Science & Business Off of Nuvectis Pharma, Inc. (NVCT).
Signal8 holds 3 ownership filings by Poradosu Enrique, all Form 4s, filed between Nov 20, 2024 and Jan 9, 2026. Those filings report 3 transactions, from Nov 19, 2024 to Jan 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Poradosu Enrique's filings is in FORT LEE, NJ.
Recent filings by Poradosu Enrique
Other insiders filing for Nuvectis Pharma, Inc. (NVCT)
- Carson Michael J., Vice President, Finance
- Mosseri Marlio Charles, 10% Owner
- BENTSUR RON, Chairman & CEO
- Hoberman Kenneth, Director
- Oliviero James F III, Director
- Sanchez Juan, Director